Picture of Pulmonx logo

LUNG Pulmonx News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapValue Trap

Pulmonx Corp expected to post a loss of 42 cents a share - Earnings Preview

* Pulmonx Corp  LUNG.OQ   LUNG.O  is expected to show a rise
in
quarterly revenue when it reports  results on February 22. 
    * The Redwood City California-based  company is expected to
report
 a 2.0% increase in revenue to $13.984 million from $13.71
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Pulmonx Corp is for
a
loss of 42 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Pulmonx
Corp is
$10​, above​ its last closing price of $9.23. ​​​

The company's guidance on November 3 2022 for the period ended
December 31 was for gross profit margin between 74% and 75%.
Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.40       -0.40      -0.38     Beat    4.2
 Jun. 30 2022  -0.42       -0.41      -0.40     Beat    2.4
 Mar. 31 2022  -0.38       -0.37      -0.43     Missed  -15.9​
 Dec. 31 2021  -0.36       -0.36      -0.35     Beat    2.9
 ​​Sep.        -0.37       -0.37      -0.28     Beat    24.8
 30 2021                                                
 Jun. 30 2021  -0.37       -0.37      -0.34     Beat    8.6​
 Mar. 31 2021  -0.38       -0.38      -0.34     Beat    10.1
 Dec. 31 2020  -0.28       -0.28      -0.27     Beat    2.9
 This summary was machine generated February 21 at 03:02 GMT. 
All figures in US dollars  unless otherwise stated

Recent news on Pulmonx

See all news